NO954175L - Anvendelse av vWF-inneholdende konsentrater som kombinasjonsterapi ved antitrombotika og fibrinolytika terapi - Google Patents
Anvendelse av vWF-inneholdende konsentrater som kombinasjonsterapi ved antitrombotika og fibrinolytika terapiInfo
- Publication number
- NO954175L NO954175L NO954175A NO954175A NO954175L NO 954175 L NO954175 L NO 954175L NO 954175 A NO954175 A NO 954175A NO 954175 A NO954175 A NO 954175A NO 954175 L NO954175 L NO 954175L
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- vwf
- antithrombotic
- fibrinolytic
- containing concentrates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Administrering av Willebrand faktor (vWF)-inneholdende medikamenter ved : terapeutisk anvendelse av blodantikoagulerende midler alene, eller i forbindelse med fibrinolytika er beskrevet. Administreringen kan foregå både samtidig og også etter den antikoagulerende og lyserende behandlingen for redusering av blødningsrisikoen i pasienter. Det er beskrevet et terapiprinsipp som separerer den ønskede virkningen til antikoagulasjon og/eller fibrinolyse fra uønskede bivirkninger ved blødningstilbøyeligheter i løpet av terapi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4437544A DE4437544A1 (de) | 1994-10-20 | 1994-10-20 | Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika |
Publications (2)
Publication Number | Publication Date |
---|---|
NO954175D0 NO954175D0 (no) | 1995-10-19 |
NO954175L true NO954175L (no) | 1996-04-22 |
Family
ID=6531287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954175A NO954175L (no) | 1994-10-20 | 1995-10-19 | Anvendelse av vWF-inneholdende konsentrater som kombinasjonsterapi ved antitrombotika og fibrinolytika terapi |
Country Status (20)
Country | Link |
---|---|
US (1) | US5571784A (no) |
EP (1) | EP0713881A3 (no) |
JP (1) | JPH08208504A (no) |
KR (1) | KR960013383A (no) |
CN (1) | CN1128168A (no) |
AU (1) | AU708670B2 (no) |
CA (1) | CA2160975A1 (no) |
CZ (1) | CZ287878B6 (no) |
DE (1) | DE4437544A1 (no) |
FI (1) | FI954964A (no) |
HR (1) | HRP950525A2 (no) |
HU (1) | HU219595B (no) |
IL (1) | IL115652A (no) |
NO (1) | NO954175L (no) |
NZ (1) | NZ280274A (no) |
PL (1) | PL183182B1 (no) |
SK (1) | SK129695A3 (no) |
TW (1) | TW398977B (no) |
UY (1) | UY24063A1 (no) |
ZA (1) | ZA958838B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5772629A (en) * | 1995-10-23 | 1998-06-30 | Localmed, Inc. | Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels |
AT405485B (de) * | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
AT409335B (de) * | 1998-11-10 | 2002-07-25 | Immuno Ag | Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen |
US6794412B1 (en) * | 1999-03-11 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin |
EP1148063A1 (de) * | 2000-04-18 | 2001-10-24 | Octapharma AG | Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung |
JP2003284570A (ja) | 2001-04-25 | 2003-10-07 | Chemo Sero Therapeut Res Inst | フォンビルブラント因子(vWF)切断酵素 |
DE102008032361A1 (de) | 2008-07-10 | 2010-01-21 | Csl Behring Gmbh | Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie |
JP5914363B2 (ja) * | 2010-02-16 | 2016-05-11 | ノヴォ ノルディスク アー/エス | 低減されたvwf結合を有する因子viii分子 |
ES2657291T3 (es) | 2013-04-22 | 2018-03-02 | Csl Ltd. | Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro |
TWI580423B (zh) * | 2013-12-24 | 2017-05-01 | 財團法人工業技術研究院 | 緩解或治療痛風之醫藥組合物及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
US5200510A (en) * | 1987-06-16 | 1993-04-06 | Zymogenetics, Inc. | Method for purifying factor viii:c, von willebrand factor and complexes thereof |
US4774323A (en) * | 1987-06-29 | 1988-09-27 | Rorer Pharmaceutical Corporation | Purification of von Willebrand Factor solutions using gel permeation chromatography |
FR2619314B1 (fr) * | 1987-08-11 | 1990-06-15 | Transgene Sa | Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant |
GB8823480D0 (en) | 1988-10-06 | 1988-11-16 | Ciba Geigy Ag | Antidote |
US5204323B1 (en) | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
FR2673632A1 (fr) * | 1991-03-08 | 1992-09-11 | Lille Transfusion Sanguine | Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique. |
DE4115453A1 (de) | 1991-05-11 | 1992-11-12 | Knoll Ag | Neue wirkstoffkombination |
US5366869A (en) * | 1991-11-08 | 1994-11-22 | Sheldon Goldstein | Multiple coagulation test device and method |
DE4203965A1 (de) * | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Antidot fuer hirudin und synthetische thrombininhibitoren |
ZA942818B (en) * | 1993-04-23 | 1995-01-30 | Bio Technology General Corp | Method of enhancing thrombolysis. |
-
1994
- 1994-10-20 DE DE4437544A patent/DE4437544A1/de not_active Withdrawn
-
1995
- 1995-09-21 EP EP95114846A patent/EP0713881A3/de not_active Withdrawn
- 1995-09-29 TW TW084110150A patent/TW398977B/zh not_active IP Right Cessation
- 1995-10-16 UY UY24063A patent/UY24063A1/es unknown
- 1995-10-18 NZ NZ280274A patent/NZ280274A/en unknown
- 1995-10-18 CZ CZ19952719A patent/CZ287878B6/cs not_active IP Right Cessation
- 1995-10-18 IL IL11565295A patent/IL115652A/xx not_active IP Right Cessation
- 1995-10-18 CN CN95118715A patent/CN1128168A/zh active Pending
- 1995-10-18 HR HRP4437544.1A patent/HRP950525A2/hr not_active Application Discontinuation
- 1995-10-18 US US08/544,867 patent/US5571784A/en not_active Expired - Fee Related
- 1995-10-18 AU AU34304/95A patent/AU708670B2/en not_active Ceased
- 1995-10-18 KR KR1019950035874A patent/KR960013383A/ko not_active Application Discontinuation
- 1995-10-18 SK SK1296-95A patent/SK129695A3/sk unknown
- 1995-10-18 FI FI954964A patent/FI954964A/fi unknown
- 1995-10-19 JP JP7270785A patent/JPH08208504A/ja active Pending
- 1995-10-19 NO NO954175A patent/NO954175L/no not_active Application Discontinuation
- 1995-10-19 PL PL95311031A patent/PL183182B1/pl unknown
- 1995-10-19 CA CA002160975A patent/CA2160975A1/en not_active Abandoned
- 1995-10-19 ZA ZA958838A patent/ZA958838B/xx unknown
- 1995-10-20 HU HU9503031A patent/HU219595B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL183182B1 (pl) | 2002-06-28 |
CZ287878B6 (cs) | 2001-03-14 |
DE4437544A1 (de) | 1996-04-25 |
SK129695A3 (en) | 1996-10-02 |
CZ271995A3 (en) | 1996-05-15 |
HRP950525A2 (en) | 1997-04-30 |
HU219595B (hu) | 2001-05-28 |
ZA958838B (en) | 1996-05-13 |
FI954964A (fi) | 1996-04-21 |
FI954964A0 (fi) | 1995-10-18 |
CN1128168A (zh) | 1996-08-07 |
NO954175D0 (no) | 1995-10-19 |
EP0713881A2 (de) | 1996-05-29 |
IL115652A0 (en) | 1996-01-19 |
AU708670B2 (en) | 1999-08-12 |
HU9503031D0 (en) | 1995-12-28 |
NZ280274A (en) | 1997-01-29 |
PL311031A1 (en) | 1996-04-29 |
EP0713881A3 (de) | 1996-08-21 |
UY24063A1 (es) | 1995-10-24 |
HUT73762A (en) | 1996-09-30 |
IL115652A (en) | 2000-08-31 |
JPH08208504A (ja) | 1996-08-13 |
US5571784A (en) | 1996-11-05 |
AU3430495A (en) | 1996-05-02 |
TW398977B (en) | 2000-07-21 |
CA2160975A1 (en) | 1996-04-21 |
KR960013383A (ko) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001012122A3 (en) | Method and system for treating cardiac arrest using hypothermia | |
WO2001049236A3 (en) | Method and system for treating cardiac arrest | |
ATE153856T1 (de) | Zusammensetzung zur stimulierung des immunsystems | |
BR9811825A (pt) | Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue | |
IL76119A0 (en) | Initiating reperfusion treatment when heart attack symptoms are present | |
DE69722401D1 (de) | Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods | |
EP0246715A3 (en) | Apparatus for the safe delivery of a beneficial agent to a patient | |
ATE114118T1 (de) | System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren. | |
FI19991893A (fi) | Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö | |
NO954175L (no) | Anvendelse av vWF-inneholdende konsentrater som kombinasjonsterapi ved antitrombotika og fibrinolytika terapi | |
IE790951L (en) | Carnitine solution | |
WO2000064456A3 (en) | Substitution infusion fluid and citrate anticoagulation | |
ATE307634T1 (de) | Photopherese-behandlung von hcv-infektionen | |
BR9713653B1 (pt) | composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico. | |
Yokoyama et al. | Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass. | |
MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
Teoh et al. | Blood conservation with membrane oxygenators and dipyridamole | |
DE69227042D1 (de) | Verfahren und zusammensetzungen zur verminderung von blutverlust | |
Takanashi et al. | Reduction of myocardial infarct size in swine: a comparative study of intraaortic balloon pumping and transapical left ventricular bypass | |
DE69943240D1 (de) | Verwendung von HGF für die Behandlung von ischämischen Erkrankungen der Extremitäten | |
Lewis et al. | Severe haemoptysis associated with viral tracheitis. | |
JPS57116017A (en) | Antithrombogenetic or anticoagulative agent | |
Henley et al. | Acute haemodilution in surgery for burns: a preliminary report | |
Tatsumi et al. | Long–Term Respiratory Assistance Using a Right Ventricular Assist Device System and a Membrane Oxygenator | |
SU1524903A1 (ru) | Способ лечени псориаза |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |